Publicacións nas que colabora con LUIS GARCÍA GARCÍA (27)

2023

  1. A Single High Dose of Flufenamic Acid in Rats does not Reduce the Damage Associated with the Rat Lithium-Pilocarpine Model of Status Epilepticus but Leads to Deleterious Outcomes

    Journal of integrative neuroscience, Vol. 22, Núm. 3, pp. 75

  2. The vasodilator naftidrofuryl attenuates short-term brain glucose hypometabolism in the lithium-pilocarpine rat model of status epilepticus without providing neuroprotection

    European Journal of Pharmacology, Vol. 939

2022

  1. PET Imaging and Neurohistochemistry Reveal that Curcumin Attenuates Brain Hypometabolism and Hippocampal Damage Induced by Status Epilepticus in Rats

    Planta Medica, Vol. 89, Núm. 4, pp. 364-376

  2. Significance of Brain Glucose Hypometabolism, Altered Insulin Signal Transduction, and Insulin Resistance in Several Neurological Diseases

    Frontiers in Endocrinology, Vol. 13

2019

  1. PET Neuroimaging Reveals Serotonergic and Metabolic Dysfunctions in the Hippocampal Electrical Kindling Model of Epileptogenesis

    Neuroscience, Vol. 409, pp. 101-110

2018

  1. Metyrapone prevents acute glucose hypermetabolism and short-term brain damage induced by intrahippocampal administration of 4-aminopyridine in rats

    Neurochemistry International, Vol. 113, pp. 92-106

2017

  1. Insulin regulates astrocytic glucose handling through cooperation with IGF-I

    Diabetes, Vol. 66, Núm. 1, pp. 64-74

  2. Metyrapone prevents brain damage induced by status epilepticus in the rat lithium-pilocarpine model

    Neuropharmacology, Vol. 123, pp. 261-273

  3. Subacute fluoxetine reduces signs of hippocampal damage induced by a single convulsant dose of 4-aminopyridine in rats

    CNS and Neurological Disorders - Drug Targets, Vol. 16, Núm. 6, pp. 694-704

2016

  1. Dysregulation of the endocannabinoid signaling system in the cerebellum and brainstem in a transgenic mouse model of spinocerebellar ataxia type-3

    Neuroscience, Vol. 339, pp. 191-209

  2. Serotonin Depletion Does not Modify the Short-Term Brain Hypometabolism and Hippocampal Neurodegeneration Induced by the Lithium–Pilocarpine Model of Status Epilepticus in Rats

    Cellular and Molecular Neurobiology, Vol. 36, Núm. 4, pp. 513-519

  3. Stimulation of brain glucose uptake by cannabinoid CB2 receptors and its therapeutic potential in Alzheimer's disease

    Neuropharmacology, Vol. 110, pp. 519-529

  4. [18F]FDG PET Neuroimaging Predicts Pentylenetetrazole (PTZ) Kindling Outcome in Rats

    Molecular Imaging and Biology, Vol. 18, Núm. 5, pp. 733-740

2015

  1. Implementation, collaborative design and analysis of a system of continuous assessment for university students through the application of objective tests

    Edulearn15: 7th international conference on education and new learning technologies

  2. In Vivo [18F] FDG PET Imaging Reveals that p-Chloroamphetamine Neurotoxicity is Associated with Long-Term Cortical and Hippocampal Hypometabolism

    Molecular Imaging and Biology, Vol. 17, Núm. 2, pp. 239-247

  3. Preliminary research on 1-(4-bromo-2-nitroimidazol-1-yl)-3-[18F]fluoropropan-2-ol as a novel brain hypoxia PET tracer in a rodent model of stroke

    European Journal of Medicinal Chemistry, Vol. 101, pp. 604-615

  4. Subacute administration of fluoxetine prevents short-term brain hypometabolism and reduces brain damage markers induced by the lithium-pilocarpine model of epilepsy in rats

    Brain Research Bulletin, Vol. 111, pp. 36-47

2014

  1. N-(4-[ 18 F]-fluoropyridin-2-yl)-N-{2-[4-(2-methoxyphenyl) piperazin-1-yl]ethyl}carboxamides as analogs of WAY100635. New PET tracers of serotonin 5-HT 1A receptors

    European Journal of Medicinal Chemistry, Vol. 85, pp. 795-806

  2. A longitudinal FDG-PET study of transgenic mice overexpressing GSK- 3β in the brain

    Current Alzheimer Research, Vol. 11, Núm. 2, pp. 175-181

  3. Longitudinal assessment of a transgenic animal model of tauopathy by FDG-PET imaging

    Journal of Alzheimer's Disease, Vol. 40, Núm. S1